Lupin, Cipla top picks from pharma space: Parag Thakkar

Parag Thakkar, Head of Sales at HDFC Securities told CNBC-TV18, "Lupin and Cipla remains our top picks. Lupin's Q3 result was good with very good management commentary on Q4 with approvals getting speed. So it remains a directionally a very positive stocks. As it has run up significantly post results it can consolidate a bit. Overall within the pharma pack it definitely remains one of the best buys."Lupin closed at Rs 1,904.00, up Rs 85.10, or 4.68 percent. It has touched an intraday high of Rs 1,911.55 and an intraday low of Rs 1,795.00.